Halozyme Therapeutics Inc.

NASDAQ: HALO
Share price (5/13/24): $43.61
Market cap (5/13/24): $5.550 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

7 Halozyme Therapeutics Inc. Expert Interviews, now on BamSEC.

Powered by Tegus.

Financials Filter

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

Prospectuses and Registrations Filter

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer

Info about tender offer or issuer

Ownership Filter

Posard Matthew L.

Miyashita Akiko Moni

Krishnan Mahesh

Henderson Jeffrey William

News Filter

Reports First Quarter 2024 Financial and Operating Results

Shareholder Vote Results, Financial Statements or Exhibits

Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

Earnings Release or Operating Update

Reports Third Quarter 2023 Financial and Operating Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission